Actively Recruiting

Phase Not Applicable
Age: 18Years - 45Years
FEMALE
Healthy Volunteers
ID06548828

Effects of a Non-nutritive Sweetener Reduction Intervention in Pregnancy and Lactation on Maternal and Infant Outcomes (the SweetPea Trial)

Led by George Washington University · Updated on 2026-02-18

324

Participants Needed

1

Research Sites

48 weeks

Total Duration

On this page

Sponsors

G

George Washington University

Lead Sponsor

C

Children's Hospital Los Angeles

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying how consuming non-nutritive sweeteners (NNS) during pregnancy and breastfeeding might affect infant obesity risk and heart health. The study focuses on pregnant women who regularly consume NNS and looks at how limiting NNS intake during pregnancy and/or lactation influences the baby's body fat, the mother's blood sugar during pregnancy, and the baby's gut bacteria and metabolism. The findings could help guide recommendations for NNS use in pregnancy and breastfeeding to support better health for mothers and babies. Participants are assigned to one of three groups: continue usual NNS consumption throughout pregnancy and lactation, restrict NNS only during lactation, or restrict NNS during both pregnancy and lactation. The NNS restriction involves education about NNS and obesity risks, handouts with foods and drinks to avoid, weekly reminders, and bi-weekly shipments of unsweetened beverages as alternatives. The control group receives education on home safety and babyproofing with weekly reminders. During the study, infants' body fat is measured at 1 and 6 months old, while mothers undergo blood sugar tests at 28 weeks gestation and postpartum. Researchers also track infants' birthweight, gestational age, and growth percentiles, along with mothers' insulin sensitivity and dietary intake. The study begins early in pregnancy and follows participants through at least 6 months postpartum to monitor health outcomes and metabolic changes.

CONDITIONS

Brief Title

Effects of a Non-nutritive Sweetener Reduction Intervention in Pregnancy and Lactation on Maternal and Infant Outcomes

Who Can Participate

Age: 18Years - 45Years
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Pregnant women at 16 weeks gestation or less
  • Singleton pregnancy
  • Frequent consumption of non-nutritive sweetener beverages (7 or more servings per week)
  • Age between 18 and 45 years
  • Able to read English at a 5th grade level or higher
  • Plan to breastfeed for at least the first 6 months after birth
  • For infant participation, the mother must be enrolled and provide consent
Not Eligible

You will not qualify if you...

  • Physical or mental conditions preventing participation
  • Use of medications affecting weight, body composition, insulin resistance, or lipids (e.g., metformin, GLP-1 agonists)
  • Tobacco or drug use during pregnancy
  • Alcohol consumption greater than one drink per week during pregnancy
  • Pre-existing gastrointestinal, inflammatory, or malabsorptive disorders (e.g., Crohn's disease, ulcerative colitis, inflammatory bowel disease)
  • Known or suspected genetic fetal abnormalities or congenital birth defects
  • History of gastric bypass surgery

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Treatment

Duration - From early pregnancy through 6 months postpartum

Participants receive interventions to reduce non-nutritive sweetener (NNS) consumption during pregnancy and/or lactation or receive counseling on home safety and babyproofing, depending on their group assignment.

Bi-weekly shipments of unsweetened beverages and weekly automated text messages for intervention groups; weekly automated text messages for control group

Trial Site Locations

Total: 1 location

1

The George Washington University

Washington D.C., District of Columbia, United States, 20037

Actively Recruiting

Loading map...

Research Team

A

Allison C Sylvetsky, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Similar Trials

Continuous Glucose Monitoring for Early Detection and Manage...

Gestational Diabetes Mellitus in Pregnancy

Actively Recruiting

10 locations

Comparison of the Detection Rates of 50 Gr-100 Gr OGTT and 7...

Gestational Diabetes

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here